Treace Medical Concepts, Inc. revised revenue guidance for the year 2023. Treace is raising its full-year 2023 revenue guidance to $191 million to $197 million, which represents approximately 35% to 39% growth over the Company?s 2022 revenue. This compares to the prior full-year 2023 revenue guidance of $190 million to $196 million.